SPDR® S&P Biotech ETF (XBI)

Add to Watchlists
Create an Alert
93.98 +0.06  +0.06% NYSE Arca Aug 17, 16:59 Delayed 2m USD
View Full Chart
XBI Price Chart

XBI Performance

  Total Return (Price) Total Return (NAV) Cat. Total Return (NAV) % Rank in Cat. (NAV)
1M -5.05% -4.93% -0.40% 99
3M 0.55% 0.46% 7.26% 96
6M 1.69% 1.74% 7.94% 93
YTD 10.80% 10.87% 12.71% 65
1Y 23.05% 23.00% 20.23% 34
3Y 7.53% 7.50% 5.81% 37
5Y 20.21% 20.22% 14.45% 12
10Y 15.50% 15.50% 13.19% 18
As of Aug. 16, 2018. Returns for periods of 1 year and above are annualized.

XBI Asset Allocation

Type % Net % Long % Short
Cash 0.00% 0.00% 0.00%
Stock 100.0% 100.0% 0.00%
Bond 0.00% 0.00% 0.00%
Convertible 0.00% 0.00% 0.00%
Preferred 0.00% 0.00% 0.00%
Other 0.00% 0.00% 0.00%
As of Aug. 15, 2018

XBI Region Exposure

Americas 100.0%
North America 100.0%
Latin America 0.00%
Greater Europe 0.00%
United Kingdom 0.00%
Europe Developed 0.00%
Europe Emerging 0.00%
Africa/Middle East 0.00%
Greater Asia 0.00%
Japan 0.00%
Australasia 0.00%
Asia Developed 0.00%
Asia Emerging 0.00%
Market Classification
% Developed Markets 100.0%
% Emerging Markets 0.00%
As of Aug. 15, 2018. Region breakdown data is calculated by using the long position holdings of the portfolio.

XBI Stock Sector Exposure

Basic Materials 0.00%
Communication Services 0.00%
Consumer Cyclical 0.00%
Consumer Defensive 0.00%
Energy 0.00%
Financial Services 0.00%
Healthcare 100.0%
Industrials 0.00%
Real Estate 0.00%
Technology 0.00%
Utilities 0.00%
As of Aug. 15, 2018

XBI Stock Market Capitalization

Giant 4.16%
Large 9.03%
Medium 25.12%
Small 51.61%
Micro 10.08%
As of Aug. 15, 2018

XBI Stock Style Exposure

Large Cap Value 3.01%
Large Cap Blend 3.01%
Large Cap Growth 7.97%
Mid Cap Value 0.00%
Mid Cap Blend 6.64%
Mid Cap Growth 20.00%
Small Cap Value 2.73%
Small Cap Blend 16.01%
Small Cap Growth 40.64%
As of Aug. 15, 2018
View More Holdings

XBI Top 10 Holdings

Symbol Name % Weight Price % Chg
ICPT Intercept Pharmaceuticals Inc 1.81% 103.44 +0.22%
SRPT Sarepta Therapeutics Inc 1.74% 130.60 +0.79%
HRTX Heron Therapeutics Inc 1.71% 38.00 +0.13%
LGND Ligand Pharmaceuticals Inc 1.70% 247.62 +3.32%
ESPR Esperion Therapeutics Inc 1.59% 48.19 +3.26%
REGN Regeneron Pharmaceuticals Inc 1.59% 375.00 +0.87%
ANAB AnaptysBio Inc 1.57% 86.19 +0.71%
VRTX Vertex Pharmaceuticals Inc 1.55% 176.04 +0.62%
NBIX Neurocrine Biosciences Inc 1.55% 114.59 +0.87%
SGEN Seattle Genetics Inc 1.54% 74.60 +0.53%
As of Aug. 15, 2018
Advertisement

XBI One Page Reports

XBI Basic Info

Style
Equity Style Mid Cap/Growth
Broad Asset Class Sector Equity
Broad Category Equity
Category Name Health
Prospectus Objective Specialty - Health
Fund Owner Firm Name SPDR State Street Global Advisors
Benchmark Index
S&P Biotechnology Select Industry TR USD
100.0%

XBI Manager Info

Name Tenure
Karl Schneider 3.75 yrs
Michael Feehily 6.76 yrs
Raymond Donofrio 1.57 yrs

XBI Net Fund Flows

1M 162.88M
3M 171.29M
6M 381.73M
YTD 722.42M
1Y 908.82M
3Y 1.642B
5Y 2.578B
10Y 2.703B
As of July 31, 2018

XBI Risk Info

Beta (5Y) 1.409
Max Drawdown (All) 49.25%
Historical Sharpe (10Y) 0.7261
Historical Sortino (All) 1.029
30-Day Rolling Volatility 18.96%
Daily Value at Risk (VaR) 1% (All) 4.84%
Monthly Value at Risk (VaR) 1% (All) 20.79%

XBI Fundamentals

Dividend Yield TTM (8-17-18) 0.20%
SEC Yield (8-15-18) 0.22%
Weighted Average PE Ratio --
Weighted Average Price to Sales Ratio 9.771
Weighted Average Price to Book Ratio 5.444
Weighted Median ROE -21.80%
Weighted Median ROA -22.92%
Forecasted Dividend Yield 0.13%
Forecasted PE Ratio 19.62
Forecasted Price to Sales Ratio 5.649
Forecasted Price to Book Ratio 4.426
Number of Holdings 120
As of Aug. 15, 2018

XBI Growth Estimates

Forecasted 5 Yr Earnings Growth 20.64%
Forecasted Book Value Growth 5.07%
Forecasted Cash Flow Growth 8.60%
Forecasted Earnings Growth 23.62%
Forecasted Revenue Growth 14.48%
As of Aug. 15, 2018

XBI Comparables

Edit

XBI Attributes

Key Dates
Inception Date 1/31/2006
Termination Date
Last Annual Report Date 6/30/2017
Last Prospectus Date 10/31/2017
Attributes
Exchange Traded Share Yes
Exchange Traded Note No
Enhanced Index Fund No
Fixed Distribution Fund No
High-Net Worth Individual Fund No
Index Fund Yes
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan Yes
Socially Responsible Fund No
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No

XBI Excel Add-In Codes

  • Name: =YCI("XBI","name")
  • Broad Asset Class: =YCI("XBI", "broad_asset_class")
  • Broad Category: =YCI("XBI", "broad_category_group")
  • Prospectus Objective: =YCI("XBI", "prospectus_objective")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.